Objectives: Therapy oral eryhtromicin with topical azelaic acid 15% and tretinoin 0,025% in papulopustular rosacea patient was effective in 1 month evaluation. There are remarkable decreased of inflammation lesions (papule and pustule), also decreased of macule and plaque for the affected area.
Introduction: Rosacea is a common skin condition with characteristic symptoms and signs, including symmetric flushing, stinging sensation, inflammatory lesions (papules and pustules), and telangiectasia on face. In most patients, the central area of the face is affected, such as the nose, forehead, chin, and perioral areas. Papulopustular rosacea (PPR) papules/pustules combined with transient or persistent facial redness, telangiectasias, red plaques, burning and stinging. The therapeutic for rosacea is avoidance of triggers and combination with medical therapy.
Materials / method: We present a 43 years old Asian female, seek for medical attention with chief complaint redness, pimples and bumps on her face and also on her scalp since 1 year ago. It’s started with pimples and bumps, also complained of stinging and burning sensation, swollen, flushing, and persistent erythema most common on central area. Physical examination found erythema papule, pustule, erythema and hyperpigmented macule, and erythema plaque. Scrapping for demodex is done and the result was negative.
Results: Therapy was given erythromycin 250 mg once daily, azelaic acid 15%, tretinoin 0,025%, sunscreen SPF 15. After 1 month therapy, there are remarkable decreased of papule and pustule for quantity, decreased of macule and plaque for the affected area.
Conclusion: Papulopustular rosacea therapy oral erythromycin with topical azelaic acid 15% and tretinoin 0,025% was effective
Declaraciones
¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No
¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No
Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.